𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Epidermal Growth Factor Receptor Inhibitors, Gefitinib and Erlotinib (Tarceva™, OSI-774), in the Treatment of Bronchioloalveolar Carcinoma

✍ Scribed by Heather DeGrendele; Chandra P. Belani; Michael C. Perry


Book ID
114411929
Publisher
CIG Media Group, LP.
Year
2003
Tongue
English
Weight
88 KB
Volume
5
Category
Article
ISSN
1525-7304

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Targeting the epidermal growth factor re
✍ Andreas P. Sutter; Michael Höpfner; Alexander Huether; Kerstin Maaser; Hans Sche 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 370 KB 👁 1 views

## Abstract Esophageal cancer is the sixth most common cause of cancer‐related death worldwide. Because of very poor 5‐year survival new therapeutic approaches are mandatory. Erlotinib (Tarceva™), an inhibitor of epidermal growth factor receptor tyrosine kinase (EGFR‐TK), potently suppresses the gr